Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.
作者信息
Hanley Brian, Roufosse Candice A, Osborn Michael, Naresh Kikkeri N
机构信息
Department of Cellular & Molecular Pathology, Northwest London Pathology, Imperial College Healthcare NHS Trust & Department of Immunology & Inflammation, Imperial College London, London, UK.
出版信息
Br J Haematol. 2020 Jun;189(6):1062-1063. doi: 10.1111/bjh.16780. Epub 2020 May 19.
PMID:32369628
Abstract
摘要
Zotero 插件